🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 7 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/03/2025 | 110,36 | 117,87 | 108,84 | 115,26 | +2,75% | 8,18% | 128.500 |
| 03/03/2025 | 125,17 | 125,17 | 110,00 | 112,18 | -8,22% | 12,12% | 164.200 |
| 28/02/2025 | 115,98 | 122,24 | 115,72 | 122,23 | +5,67% | 5,62% | 149.300 |
| 27/02/2025 | 111,74 | 123,51 | 111,74 | 115,67 | +0,57% | 10,53% | 155.800 |
| 26/02/2025 | 119,54 | 120,72 | 114,33 | 115,01 | -3,11% | 5,35% | 138.900 |
| 25/02/2025 | 117,07 | 119,59 | 114,77 | 118,70 | +1,39% | 4,12% | 102.600 |
| 24/02/2025 | 120,81 | 120,92 | 116,99 | 117,07 | -2,98% | 3,25% | 95.300 |
| 21/02/2025 | 123,02 | 123,02 | 119,02 | 120,67 | -1,10% | 3,25% | 136.700 |
| 20/02/2025 | 122,13 | 122,91 | 119,54 | 122,01 | +0,01% | 2,76% | 148.000 |
| 19/02/2025 | 118,86 | 122,62 | 118,23 | 122,00 | +1,68% | 3,69% | 106.600 |
| 18/02/2025 | 120,25 | 121,65 | 117,63 | 119,99 | -0,01% | 3,34% | 122.800 |
| 14/02/2025 | 114,03 | 121,26 | 113,58 | 120,00 | +5,33% | 6,74% | 119.000 |
| 13/02/2025 | 111,76 | 115,99 | 111,52 | 113,93 | +2,28% | 4,00% | 67.700 |
| 12/02/2025 | 110,81 | 112,66 | 110,42 | 111,39 | -1,22% | 2,02% | 77.900 |
| 11/02/2025 | 114,75 | 114,75 | 111,19 | 112,77 | -1,18% | 3,10% | 59.700 |
| 10/02/2025 | 115,12 | 115,75 | 113,03 | 114,12 | -0,93% | 2,36% | 53.200 |
| 07/02/2025 | 117,04 | 118,64 | 113,92 | 115,19 | -2,25% | 4,03% | 68.500 |
| 06/02/2025 | 117,36 | 119,26 | 116,33 | 117,84 | +0,45% | 2,50% | 64.300 |
| 05/02/2025 | 117,92 | 119,11 | 116,49 | 117,31 | +0,04% | 2,22% | 71.900 |
| 04/02/2025 | 114,12 | 117,39 | 113,91 | 117,26 | +2,18% | 3,05% | 43.800 |
| 03/02/2025 | 113,76 | 116,51 | 113,27 | 114,76 | -1,54% | 2,85% | 57.000 |
| 31/01/2025 | 117,85 | 119,38 | 115,00 | 116,55 | -1,76% | 3,72% | 68.000 |
| 30/01/2025 | 120,00 | 122,34 | 118,22 | 118,64 | -0,24% | 3,43% | 73.600 |
| 29/01/2025 | 117,48 | 119,46 | 116,36 | 118,92 | +0,69% | 2,64% | 81.600 |
| 28/01/2025 | 117,33 | 118,43 | 115,98 | 118,11 | +0,71% | 2,09% | 52.500 |
| 27/01/2025 | 114,75 | 119,11 | 114,75 | 117,28 | +1,96% | 3,80% | 85.200 |
| 24/01/2025 | 114,91 | 115,81 | 112,50 | 115,03 | -0,30% | 2,88% | 77.200 |
| 23/01/2025 | 115,79 | 115,86 | 112,79 | 115,38 | -0,41% | 2,65% | 73.400 |
| 22/01/2025 | 117,26 | 119,00 | 113,99 | 115,86 | -1,28% | 4,27% | 118.900 |
| 21/01/2025 | 113,01 | 117,53 | 112,53 | 117,36 | +4,89% | 4,42% | 106.100 |